Trial Profile
Open Phase III Study of ME2080 in Patients with Dravet Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Stiripentol (Primary) ; Clobazam; Valproate
- Indications Dravet syndrome
- Focus Therapeutic Use
- Sponsors Meiji Seika Pharma
- 28 Nov 2015 Endpoint (Responder Rate) has been met, according to results published in the Epilepsy Research.
- 28 Nov 2015 New trial record